CO-CHAIR:

Nathaniel Lipkus

Partner at Osler Hoskin & Harcourt LLP (Toronto, Ontario)

Alexis Sciuk

Director, Access and Government Relations, Ontario and Private Sector at Pfizer Canada Inc.

SPEAKERS:

Sylvie Bouchard

Director of Medication at INESSS (Montréal Quebec)

Mathew Brougham

CEO & Principal Consultant at Brougham Consulting Inc.

Martin Chung

Assistant Vice President, Strategic Health Management at Equitable Life of Canada

Vincenzo Ciampi

Executive Director, Innovation and Strategic Projects at Sandoz Canada (Boucherville, Québec)

Brent Fraser

Vice President, Pharmaceutical Reviews at CADTH (Ottawa, Ontario)

Scott Gavura

Director, Provincial Drug Reimbursement Programs at Cancer Care Ontario

Mathew Kellison

Director of Regulatory Affairs & Outreach at Patent Medicine Pricing Review Board (Ottawa, Ontario)

Jillian Clare Kohler

Professor at Leslie Dan Faculty of Pharmacy & Munk School of Global Affairs (University of Toronto)

Sang Mi Lee

Senior Pharmacist at Pan-Canadian Pharmaceutical Alliance (Toronto, Ontario)

Nathaniel Lipkus

Partner at Osler Hoskin & Harcourt LLP (Toronto, Ontario)

Susan Marlin

President & CEO at Clinical Trials Ontario (Toronto, Ontario)

Barbara Martinez

Practice Leader, Benefits Solution at The Great-West Life Assurance Company (North York, Ontario)

Chris Murray

Director, Health Economics and Outcomes Research at Canopy Growth Corp. (Smiths Falls, Ontario)

Ned Pojskic

Leader, Pharmacy & Health Provider Relations at Green Shield (North York. Ontario)

Kobina Quansah

Outcomes Research Manager at Boehringer Ingelheim (Burlington, Ontario)

William Sarraille

Partner at Sidley Austin LLP (Washington, D.C.)

Sumeet Singh

Director at Cornerstone Research Group

Louis Thériault

Vice President, Policy and Research at Innovative Medicines Canada (Ottawa, Ontario)

Ron Weingust

Consultant at RWW Consultants (Richmond Hill, Ontario)

Joan Weir

Director, Health and Disability Policy at Canadian Life and Health Insurance Association

Durhane Wong Rieger

President & CEO at Canadian Organization for Rare Disorders (Toronto, Ontario)

Sara Zborovski

Partner at Norton Rose Fulbright Canada LLP (Toronto, Ontario)